From patient derived xenografts to the development of clinical trials: the HERACLES study in HER2-amplified metastatic colorectal cancer

Date 07 October 2016
Event ESMO 2016 Congress
Session Joint Symposium ESMO-EACR: How mouse models can help develop better targeted therapies
Topics Basic Science
Translational Research
Presenter Salvatore Siena
Authors S. Siena
  • Niguarda Cancer Center, Grande Ospedale Metroploitano Niguarda, 20162 - Milan/IT